Market Overview

UPDATE: Humana Q2 Revenue Beats Estimates

Related HUM
Insurers To Continue Struggling With ACA In 2016
Earnings Recap For February 10
Now Humana Says It Might Bail On ObamaCare (Investor's Business Daily)

Humana (NYSE: HUM) reported an 18% drop in its second-quarter profit.

The Louisville, Kentucky-based company's quarterly profit slipped to $344 million, or $2.19 per share, versus a year-ago profit of $420 million, or $2.63 per share. The decline in profit was primarily due to investments in health-care exchanges and state-based contracts and higher specialty drug costs associated with a new treatment of Hepatitis C as well as a lower diluted share count.

Its revenue jumped 18% to $12.22 billion versus $10.32 billion. However, analysts were projecting earnings of $2.19 a share on revenue of $11.94 billion.

Humana's total Medicare Advantage membership rose 14% year-to-date to over 2.8 million, while Medicare stand-alone PDP membership climbed 19% to around 3.9 million.

Individual commercial membership jumped 1225 year-to-date to over 1.1 million, while state-based Medicaid membership jumped 91% to around 163,000.

For the first-half, Healthcare Services segment pretax income jumped 62% y/y.

The company reaffirmed its FY14 earnings forecast of $7.25 to $7.75 per share.

“Our second-quarter and year-to-date results show the effectiveness of our integrated care delivery model in driving robust membership growth in our Medicare, health care exchange and state-based Medicaid businesses," said Bruce D. Broussard, President and Chief Executive Officer of Humana.

Humana shares fell 2.60% to close at $127.52 yesterday.

Posted-In: profitEarnings News Guidance


Related Articles (HUM)

View Comments and Join the Discussion!

Get Benzinga's Newsletters